- Home
- PLX vs HAIA Comparison
PLX vs HAIA Comparison
Compare PLX & HAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- HAIA
- Stock Information
- Founded
- PLX 1993
- HAIA 2021
- Country
- PLX Israel
- HAIA United States
- Employees
- PLX N/A
- HAIA N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- HAIA Blank Checks
- Sector
- PLX Health Care
- HAIA Finance
- Exchange
- PLX Nasdaq
- HAIA Nasdaq
- Market Cap
- PLX 79.4M
- HAIA 68.8M
- IPO Year
- PLX 1998
- HAIA 2021
- Fundamental
- Price
- PLX $1.68
- HAIA $11.55
- Analyst Decision
- PLX
- HAIA
- Analyst Count
- PLX 0
- HAIA 0
- Target Price
- PLX N/A
- HAIA N/A
- AVG Volume (30 Days)
- PLX 439.0K
- HAIA 6.8K
- Earning Date
- PLX 11-14-2024
- HAIA 01-01-0001
- Dividend Yield
- PLX N/A
- HAIA N/A
- EPS Growth
- PLX N/A
- HAIA N/A
- EPS
- PLX N/A
- HAIA 0.13
- Revenue
- PLX $45,667,000.00
- HAIA N/A
- Revenue This Year
- PLX N/A
- HAIA N/A
- Revenue Next Year
- PLX $88.94
- HAIA N/A
- P/E Ratio
- PLX N/A
- HAIA $85.87
- Revenue Growth
- PLX N/A
- HAIA N/A
- 52 Week Low
- PLX $0.82
- HAIA $10.89
- 52 Week High
- PLX $1.90
- HAIA $11.57
- Technical
- Relative Strength Index (RSI)
- PLX 74.56
- HAIA 65.80
- Support Level
- PLX $1.14
- HAIA $11.50
- Resistance Level
- PLX $1.75
- HAIA $11.52
- Average True Range (ATR)
- PLX 0.12
- HAIA 0.03
- MACD
- PLX 0.05
- HAIA 0.00
- Stochastic Oscillator
- PLX 87.29
- HAIA 92.00
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About HAIA Healthcare AI Acquisition Corp.
Healthcare AI Acquisition Corp is a blank check company.